Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation

Affiliations

¹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
² Department of Biological Sciences, SRM University-AP, Amaravati, 522502, India.
³ Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, BIOSIT - UMS3480, F-35000, Rennes, France.
⁴ Research Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.
⁵ Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
⁶ Medical University of Vienna, Vienna, Austria.
⁷ Ribon Therapeutics, Cambridge, MA, 02140, USA.
⁸ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. rebecca.smith@path.ox.ac.uk.
⁹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. ivan.ahel@path.ox.ac.uk.

^# Contributed equally.

Published Erratum

Pulak Kar et al. EMBO J. 2024 Nov.

. 2024 Nov;43(21):5327.

doi: 10.1038/s44318-024-00247-6.

¹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
² Department of Biological Sciences, SRM University-AP, Amaravati, 522502, India.
³ Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, BIOSIT - UMS3480, F-35000, Rennes, France.
⁴ Research Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.
⁵ Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
⁶ Medical University of Vienna, Vienna, Austria.
⁷ Ribon Therapeutics, Cambridge, MA, 02140, USA.
⁸ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. rebecca.smith@path.ox.ac.uk.
⁹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. ivan.ahel@path.ox.ac.uk.

^# Contributed equally.

Abstract

PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.
Kar P, Chatrin C, Đukić N, Suyari O, Schuller M, Zhu K, Prokhorova E, Bigot N, Baretić D, Ahel J, Elsborg JD, Nielsen ML, Clausen T, Huet S, Niepel M, Sanyal S, Ahel D, Smith R, Ahel I. Kar P, et al. EMBO J. 2024 Jul;43(14):2929-2953. doi: 10.1038/s44318-024-00126-0. Epub 2024 Jun 4. EMBO J. 2024. PMID: 38834853 Free PMC article.